eClinical Solutions Market By Top Players, Regions, Trends, Opportunity And Forecast 2022 - 2030.

The global eClinical solutions market size was estimated at USD 7.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.6% from 2022 to 2030. Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to provide a fillip to the market. The COVID-19 pandemic boosts the adoption of the market, as companies in the market were investing in better healthcare IT solutions to help in tackling the pandemic.

Gather more insights about the market drivers, restrains and growth of the Global eClinical Solutions Market

For instance, in April 2020, eClinical Solutions LLC, developed the elluminate COVID-19 analytics, which was based on feedback from the industry and its clients for helping the sponsors manage the impact of COVID-19 on their ongoing clinical trials. The burgeoning trend of outsourcing clinical trials to contract research organizations (CROs) along with a rising number of CROs and life sciences organizations is poised to help the market gain tremendous traction in the coming years. In addition, growing research programs in Asian countries and the development of cost-effective modules are anticipated to stir up the demand for eClinical solutions.

Moreover, the presence of a stringent regulatory structure for clinical trials and a heightened need for safety monitoring is playing a vital role in the growth of the market for eClinical solutions in developed economies such as the U.S.For instance, the U.S. Department of Health and Human Services and the National Institutes of Health are tightening clinical trial registration requirements and promoting clinical data sharing. Surging demand for software solutions for clinical trials by pharma and biopharma companies is one of the primary growth stimulants of the market for eClinical solutions. Apart from this, increasing government grants to substantiate trials and widening the end-user base for eClinical solutions are likely to boost the market for eClinical solutions during the review period.

Browse through Grand View Research's Healthcare IT Industry Related Reports

•      Personalized Medicine Market- The global personalized medicine market size was valued at USD 493.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. The growth of the market can be primarily attributed to the rising interest in biomarkers identification for therapy, diagnosis, and prognosis for personalized medicine development.
• Digital Transformation Market - The global digital transformation market size was evaluated at USD 608.72 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 23.1% from 2022 to 2030.

eClinical Solutions Market Segmentation

Grand View Research has segmented the global eClinical solutions market on the basis of product, delivery mode, development phase, end-use, and region:

• eClinical Solutions Product Outlook (Revenue, USD Million, 2017 - 2030)

o   Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)

o   Clinical Trial Management Systems (CTMS)

o   Clinical Analytics Platforms

o   Randomization and Trial Supply Management (RTSM)

o   Clinical Data Integration Platforms

o   Electronic Clinical Outcome Assessment (eCOA)

o   Safety Solutions

o   Electronic Trial Master File (eTMF)

• eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)

o   Web-hosted (On-Demand)

o   Licensed Enterprise (On-premise)

o   Cloud-based

• eClinical Solutions Development Phase Outlook (Revenue, USD Million, 2017 - 2030)

o   Phase I

o   Phase II

o   Phase III

o   Phase IV

• eClinical Solutions End-use Outlook (Revenue, USD Million, 2017 - 2030)

o   Hospitals/Healthcare providers

o   CROs

o   Academic Institutes

o   Pharma& Biotech Organizations

o   Medical Device Manufacturers

• EClinical Solutions Regional Outlook (Revenue, USD Million, 2017 - 2030)

o   North America

o   Europe

o   Asia Pacific

o   Central & SouthAmerica

o   Middle East & Africa

Market Share Insights

January 2021: Parexel International Corporation collaborated with Signify Health for offering new solutions to their customers for enabling access to a more diverse and traditionally underrepresented population for their clinical trials.

December 2020:ERT and Bioclinica announced their merger. The merger is aimed at making ERT and Bioclinica leaders in clinical trial endpoint technology.

Key Companies profiled:

Some prominent players in the global EClinical Solutions market include

• DATATRAK International, Inc
• Oracle
• Parexel International Corporation
• DassaultSystemes
• Bioclinica
• CRF Health
• ERT Clinical
• eClinicalWorks
• IBM Watson Health
• Anju Life Sciences Software
• eClinical Solutions

Order a free sample PDF of the eClinical Solutions Market Intelligence Study, published by Grand View Research.